Clinical Trial

Beginning to Assess an Appropriate CONtrol for Oral Food Challenges in Alpha-Gal Syndrome (CoFAR-13) - BeACON4AG

Study acronym: BeACON4AG
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a multisite, randomized, double-blind, controlled cross-over trial with detailed characterization of participants with varying clinical sub-phenotypes of Alpha-gal Syndrome (AGS) who are then evaluated by oral food challenges with alpha-gal Knock Out (KO) pork versus Wild Type (WT) pork. Each participant will serve as their own control and ingest both alpha-gal-KO and WT pork on different days, with a minimum of an 8-day washout period between oral food challenges. The primary objective is to determine whether the odds of positive challenges among participants with suspected alpha-gal syndrome are lower with alpha-gal Knock Out (KO) pork as compared to Wild Type (WT) pork during Double Blind Food Challenge (DBFC)
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-05-22; most recent amendment 2026-07-01.
Trial Details
NCT Number NCT07611435
Lead Sponsor National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: Consortium for Food Allergy Research (CoFAR), Allergy & Asthma Statistical and Clinical Coordinating Center: Rho, Inc
Conditions Alpha-Gal Syndrome, Allergy
Enrollment 160 participants
Start Date 2026-07-30
Primary Completion 2031-09-30 (estimated)
Study Completion 2032-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-06